发明名称 |
Use of pegylated interferon alpha for renal cell carcinoma treatment. |
摘要 |
Methods for treating treatment-naive as well as treatment-experienced patients having RCC to achieve at least a partial tumor response involving administering a therapeutically effective amount of pegylated interferon-alfa, e.g., pegylated interferon alfa-2b as monotherapy or in association with a therapeutically effective amount of IL-2 are disclosed. |
申请公布号 |
ZA200108169(B) |
申请公布日期 |
2003.01.06 |
申请号 |
ZA20010008169 |
申请日期 |
2001.10.04 |
申请人 |
SCHERING CORPORATION |
发明人 |
ESTHER HELEN ROSE;MARY ELLEN RYBAK |
分类号 |
A61K47/48;A61K9/08;A61K31/513;A61K38/00;A61K38/21;A61K47/34;A61P13/12;A61P35/00 |
主分类号 |
A61K47/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|